Robert B. Cameron

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?”.

What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231198446

N/A

0DataRank · unranked

7 citations

Jacobi Hines, Valter Torri, Luca Porcu, Jessica Donington, Christine M. Bestvina +5 more

High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non–Small Cell Lung Cancer in Patients

Cancer Discovery(2025)10.1158/2159-8290.cd-23-1319

N/A

0DataRank · unranked

16 citations

Nia G. Hammond, Alpaslan Tasdogan, Massar Alsamraae, Chendong Yang, Robert B. Cameron +40 more